Articles related to Pediatric Infectious Diseases

Registry-recorded antibiotic prescriptions beginning in later childhood were associated with IBS at age 24 in a Swedish cohort. Higher prescription counts accompanied higher odds, but the findings do not establish causality or when symptoms began.

A simulation of one US birth cohort projected more chronic hepatitis B infections under deferred or shared decision-making vaccination than universal birth-dose vaccination, with estimates dependent on coverage and transmission assumptions.

Children exposed to maternal Tdap vaccination had lower pertussis toxin and diphtheria antibody concentrations at ages 3 and 4, but their responses matched controls after a preschool DTaP booster in this small Finnish follow-up.

Invasive pneumococcal disease declined among US children across vaccine eras, but incidence remained substantially higher among those with chronic medical or immunocompromising conditions, with relative disparities widening over the 25-year claims-based study.

Updated joint ESPGHAN/NASPGHAN guidelines for pediatric Helicobacter pylori infection emphasize antimicrobial stewardship, susceptibility-guided therapy, and more selective testing strategies. The recommendations also introduce several changes regarding screening, incidental findings, and management of associated conditions.

The American Academy of Pediatrics expanded its definition of children at high risk for severe RSV disease who should receive immunization before their second RSV season, adding several congenital, developmental, and prematurity-related conditions to existing eligibility criteria.